Results 121 to 130 of about 2,911,959 (179)

Determination of Seroprevalence of Chronic Hepatitis B, C and D: A Cross-Sectional Study From Türkiye. [PDF]

Public Health Nurs
Tarhan MS.
europepmc   +1 more source

A Thermosensitive Hydroxybutyl Chitosan/Microalgae Hydrogel With Antibacterial and Antioxidant Activities for Accelerating Burn Wound Healing. [PDF]

Macromol Biosci
Feng Y, Lin D, Li Z, Xu X, Li X, Liu B, Li L, Ji X, Liang B, Yao F, Zhang H, Li J.   +11 more
europepmc   +1 more source

Clinical Impact of Routine HBV Screening in Oncologic Patients Prior to Chemotherapy. [PDF]

J Clin Med
Abu Sini H, Shirron N, Litvak M, Nasser R, Abu Baker F, Hazzan R, Haim N, Saadi T.   +7 more
europepmc   +1 more source

Hepatitis B Virus Reactivation During Rituximab Therapy Despite Anti-HBs Positivity: A Case Report. [PDF]

Cureus
Belhocine R, Lagdali N, Kadiri M, Mohamed B, Ajana FZ.   +4 more
europepmc   +1 more source

Genetic Diversity, Occult Hepatitis B, and Mutational Signatures in Migrants from Regions with Varying HBV Endemicity: Importation of Diverse Viral Variants into St. Petersburg, Russia. [PDF]

Int J Mol Sci
Serikova EN, Ostankova YV, Shchemelev AN, Pechnikova NA, Ramsay ES, Totolian AA.   +5 more
europepmc   +1 more source

HBV breakthrough infection in individuals born to mothers with HBV infection: a systematic review and meta-analysis. [PDF]

BMC Public Health
Pan Y, Jia Z, Zhang Y, Wu Y, Jiang J.
europepmc   +1 more source

Prevalence of hepatitis B surface antibodies and hepatitis B exposure in Belgium: results from a nationwide population-based serosurvey. [PDF]

BMC Infect Dis
Furquim d'Almeida A, Ho E, Beutels P, Maertens K, Hens N, Van Damme P, Theeten H, Vanwolleghem T.   +7 more
europepmc   +1 more source

Hepatitis B Vaccination in People Living with HIV: Bridging the Immunological Gap. [PDF]

Vaccines (Basel)
Radi C, Abu Faraj J, Idriss J, Gromer DJ, Saint-Victor D, Eberhardt CS, Rouphael N, Kalash S.   +7 more
europepmc   +1 more source

Hepatitis B Screening, Antiviral Prophylaxis, and Reactivation Risk in Rituximab-Treated Patients: A 17-Year Population-Based Cohort Study Highlighting Current Practices and Gaps. [PDF]

Dig Dis Sci
Baker FA, Tatour M, Yehya A, Saadi T, Hazzan R.   +4 more
europepmc   +1 more source

Immune correlates of outcomes after nucleos(t)ide analogue withdrawal in chronic hepatitis B: direct evidence, mechanistic context, and candidate biomarkers. [PDF]

Front Immunol
Xu Z, Liu Y, Cheng L, Xu J.
europepmc   +1 more source